Why Pfizer Will Find It Hard to Appease Its Activist Investor

HS 08/10/2024
Advertisements




The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.



Source link

More Stories

Financial Services Roundup: Market Talk

HS 21/11/2024

Energy & Utilities Roundup: Market Talk

HS 21/11/2024

Boohoo Changes Chairman as Frasers Calls For Removal

HS 21/11/2024

You may have missed

How Fruit Bowls With Yoghurt May Be Actually Destroying Your Gut Health

HS 21/11/2024

Indian embassy cancels more consular camps in Canada over security concerns – Times of India

HS 21/11/2024

From Malai Lassi To Mawa, A Sneak Peek Into Matt Prestons Foodie Trip To Jaipur

HS 21/11/2024

The rise of SECI, the little-known miniratna PSU – Times of India

HS 21/11/2024

Energy & Utilities Roundup: Market Talk

HS 21/11/2024